dr peter attia semaglutide Medical FAQs Semaglutide | Potere

Ill be completely honest, I listened to a podcast by Dr

These side effects are usually dose-dependent, meaning they can increase with higher doses of the medication

Other options include SGLT2 inhibitors such as dapagliflozin or empagliflozin, DPP-4 inhibitors like sitagliptin, or traditional agents such as metformin (if not already prescribed), sulfonylureas, or insulin therapy

Full clinical and market details here: Preapared by HEALTHCARE ALLIANCE VIETNAM #GLP1 #ObesityTreatment #WeightLossTherapy #Pharma #NovoNordisk #HealthcareInnovation #Cardiometabolic #Biopharma #HealthcareAlliance #HealthcareInsights To view or add a comment, sign in Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy pill, the first oral GLP-1 medicine for obesity in the US.3 Wegovy pill is used with a reduced calorie diet and increased physical activity for adults with obesity, or with overweight who also have weight-related medical problems, to help them lose weight and keep it off.3 Wegovy pill is also indicated to reduce the risk of major adverse cardiovascular events (MACE) such as death, heart attack, or stroke in adults with overweight or obesity and established cardiovascular disease

Limiting heavy, greasy, or sugary foods may help reduce side effects and promote steady progress

Simultaneously, obesity and IR amplify the risk of complications by increasing the likelihood of gestational diabetes mellitus and pregnancy-induced hypertension (33, 34)